Author

G. Choudhary

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

A. E. Belyvech· 1 shared A. Pellagatti· 1 shared A. Shastri· 1 shared A. Vang· 1 shared A. Verma· 1 shared A. Wickrema· 1 shared A. Zimmer· 1 shared B. Agianian· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. E. Belyvech

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Reduction in activity and abundance of mitochondrial electron transport chain supercomplexes in pulmonary hypertension-induced right ventricular dysfunction

W. Ma, P. Zhang, A. Vang, A. Zimmer, S. Huck, P. Nicely, E. Wang, T. J. Mancini, J. Owusu-Sarfo, C. F. Cavarsan, A. E. Belyvech, K. S. Campbell, D. Terentyev, G. Choudhary, R. T. Clements

This study shows reduced mitochondrial supercomplex activity and abundance in pulmonary hypertension-induced right ventricular dysfunction in rats and humans.

bioRxiv · Mar 8, 2024 · PreprintPathology

Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations

G. Choudhary, A. Pellagatti, B. Agianian, M. Smith, T. D. Bhagat, S. Gordon-Mitchell, S. Pandey, N. Shah, S. Aluri, L. Schwartz, V. Steeples, R. Booher, M. Ramachandra, M. Samson, M. Carbajal, , A. Verma

This study identifies a longer, oncogenic IRAK4 isoform caused by SF3B1 mutations in MDS/AML, which is targetable by IRAK4 inhibition.

bioRxiv · Mar 9, 2022Cancer Biology